Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU, China, Dec. 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...

2024-12-20 20:20 5338

CNN explores the fascinating science of sweat - On Vital Signs

HONG KONG, Dec. 20, 2024 /PRNewswire/ -- With rapid advancements in sweat diagnostics, CNN's Chief Medical Correspondent, Dr. Sanjay Gupta , explores how one of the body's most overlooked fluids has the potential to transform healthcare...

2024-12-20 13:16 1762

CNN explores the fascinating science of sweat - On Vital Signs

15 Years of Steadfast Efforts, Building Blocks of the Future - CPIC celebrates 15th Anniversary of HKSE Listing

SHANGHAI, Dec. 20, 2024 /PRNewswire/ -- On December 17-18, CPIC hosted a series of events to celebrate the 15th anniversary of its listing in Hong Kong Stock Exchange. The events, which included an investment forum, a gala dinner and a symphony concert, provided a multifaceted review of the compa...

2024-12-20 13:15 1590

VISTA Eye Specialist Redefines Healthcare Marketing in Malaysia with Groundbreaking "31 Days Challenge" Campaign

PETALING JAYA, Malaysia, Dec. 20, 2024 /PRNewswire/ -- Leading the way in advanced eye care and healthcare innovation,VISTA Eye Specialist ('VISTA') has set a new benchmark for digital healthcare marketing inMalaysia with its transformative"31 Days Challenge" campaign. Conducted in August and Oct...

2024-12-20 08:00 1789

VISTA Eye Specialist Redefines Healthcare Marketing in Malaysia with Groundbreaking

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

* Based on promising early clinical results from PeproMene Bio's PMB-102 Phase 1 study, they will receive$6M USD upfront plus an additional $5M USD in conditional tranched investments from the Institute for Follicular Lymphoma Innovation. * Patients with relapsed/refractory follicular lympho...

2024-12-19 23:00 1682

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

Collaboration to Focus on Nutrition, Cellular Rejuvenation, Protein, Collagen and Overall Wellness IM8, a New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com CHARLOTTE, N.C., Dec. 19, 2024 /PRNewswire/ -- Prenetics' (NASDAQ:PRE) IM8, a...

2024-12-19 21:30 1951

Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

MELBOURNE, Australia and INDIANAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has completed the installation of two new cyclotrons at Telix Manufacturing Solutions (TMS) in Brussels South,Belgium, facilita...

2024-12-19 17:02 2521

"You've Got a Friend" Charity Concert Aims to Promote Mental Wellness

HONG KONG, Dec. 19, 2024 /PRNewswire/ -- The "You've Got a Friend" charity concert, organized by the Hong Kong Mental Wellness Association, will take place from April 9 to 11, 2025, at the Rita Tong Liu Drama Theatre of the Hong Kong Academy for Performing Arts. The concert aims to raise public a...

2024-12-19 12:55 2257

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

LOS ANGELES, Dec. 19, 2024 /PRNewswire/ -- Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward in the fight against pancreatic cancer. The company is announcing availability of its OncoSweep™ Pancreas Spotlight, a liquid bi...

2024-12-19 01:00 1887

DNAnexus Recognized by Frost & Sullivan for Ability to Integrate and Synchronize Diverse Clinical and Multi-omics Data

Leading cloud-based enterprise platform for precision health data empowers biopharma companies with actionable insights to accelerate drug discovery and development SAN ANTONIO, Dec. 18, 2024 /PRNewswire/ -- Frost & Sullivan researched the bioinformatics-based drug discovery and development ...

2024-12-18 22:00 1139

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

* In a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg, subcutaneous(SQ), once every four weeks plus semaglutide, 30 nmol/kg, SQ, once daily), demonstrated superior weight loss compared to semaglutide monotherapy (30 nmol/kg, SQ, once daily), show...

2024-12-18 21:43 2158

Apollo Care Secures Growth Equity Investment from Flexpoint Ford to Accelerate Patient Access and Commercial Solutions Initiatives

* Strategic investment from Flexpoint Ford to drive Apollo Care's growth initiatives * Proceeds will be used to expand Apollo Care's innovation pipeline, enhance existing technology, and scale operations * Flexpoint Ford's Jonathan Oka and Elliot Lauzen join Apollo Care's Board of Director...

2024-12-18 21:00 1346

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial)

BEIJING and BRIDGEWATER, N.J., Dec. 18, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087.SH), is pleased to announce that the Food and Drug Administration (" FDA ") has cleared the Investigational New Drug (IND) application for GZR18 Injection to conduct ...

2024-12-18 19:34 2326

Ayala Corporation partners with ING to secure sustainable finance €50 million, advancing healthcare growth in the Philippines

MANILA, Philippines, Dec. 18, 2024 /PRNewswire/ -- Ayala Corporation signed a €50 million (₱3.1 Billion) social loan from leading European bank ING to support AC Health's portfolio growth. From left, Wing Bayoneta, Produ...

2024-12-18 17:46 1927

Ayala Corporation partners with ING to secure sustainable finance €50 million, advancing healthcare growth in the Philippines

Xinhua Silk Road: Evaluation report highlights Seoul 120 hotline for its efficient operation

BEIJING, Dec. 18, 2024 /PRNewswire/ -- Seoul 120 hotline has contributed to efficient city operation, according to the Evaluation Report on Worldwide City Hotline Services and Governance Effectiveness (2024) released on Wednesday. Photo shows the c...

2024-12-18 16:14 1264

Xinhua Silk Road: Evaluation report highlights Seoul 120 hotline for its efficient operation

Fosun International Awarded TVB's Highest Honor "Outstanding ESG Award"

HONG KONG, Dec. 18, 2024 /PRNewswire/ -- On 13 December 2024, the "TVB ESG Awards" ceremony, hosted by Television Broadcasts Limited (hereinafter referred to as "TVB"), was held at the Hong Kong Convention and Exhibition Centre. Fosun International was honored with the highest accolade, the "Outs...

2024-12-18 11:43 1639

TPIsoftware Expedites Underwriting and Claims Processing for Cathay Life Insurance

TAIPEI, Dec. 18, 2024 /PRNewswire/ -- As a leading expert in Fintech and Insurtech, TPIsoftware has once showcased its digital expertise in delivering tech-driven solutions for Cathay Life Insurance. With Cathay utilizing TPIsoftware's Business Process Management (BPM) platform digiFlexis and dig...

2024-12-18 11:10 1256

Neurizon Files IND Application to Support HEALEY ALS Platform Trial

Highlights: * IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001 * The IND is a comprehensive dossier of information, including animal and human studies, pharmacokinetic analyses, toxicology studies,...

2024-12-18 10:59 1660

Nutiani Unveils Top Five Consumer Trends for 2025

TOKYO, Dec. 18, 2024 /PRNewswire/ -- Nutrition science solutions brand Nutiani recently announced its top five consumer trends for 2025 in its live Health & Nutrition Trends Webcast. Presented byRebecca Cuthbertson, Head of Marketing, Advanced Nutrition, Fonterra, and Pooja Passi, Head of Insight...

2024-12-18 09:00 2187

Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China Patients

SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that the first prescription for VELSI...

2024-12-18 08:00 1413

1 234 5 6 ... 575